Kazakhstan Becomes First Central Asian Country to Achieve WHO ML3 Status for Drug and Vaccine Regulation
Kazakhstan has become the first country in Central Asia to receive the "Maturity Level 3" (ML3) status from the World Health Organization (WHO) for regulating medicines and imported vaccines, as reported on the UN website. This status officially confirms that the national regulatory system meets international standards and is capable of ensuring a high level of control over the quality, safety, and efficacy of medical products.











